Additionally, a randomized controlled trial by Fereidouni et al. found that ASX (6 mg/day for 8 weeks) significantly decreased IL-6 and IL-1β levels in infertile women with polycystic ovary syndrome (Fereidouni et al., 2024). The gene discussed is IL6; the disease is polycystic ovary syndrome.